Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 11, pp. 1240-1240
Closed Access | Times Cited: 23

Showing 23 citing articles:

Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study
Iraj Hasan, Lauren Parsons, Sabrina Duran, et al.
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 2, pp. 255-258
Closed Access | Times Cited: 24
Systemtherapie der AD
Thomas Werfel
hautnah dermatologie (2025) Vol. 41, Iss. S1, pp. 6-15
Closed Access
Cutaneous T‐cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
Robert Stuver, Stephen W. Dusza, Zachary D. Epstein‐Peterson, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Closed Access | Times Cited: 4
Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
Viviane Liao, Leore Lavin, Michael M Ong, et al.
The Journal of Dermatology (2025)
Closed Access
Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities
Paneez Khoury, Florence Roufosse, Fei Li Kuang, et al.
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 3
Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System
Leore Lavin, Stephen W. Dusza, Shamir Geller
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 1
Reply to: “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”
Khalaf Kridin, Ralf J. Ludwig
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 6, pp. e169-e170
Open Access | Times Cited: 1
A review of comorbidities in atopic dermatitis
Ozlem Apti Sengkioun, Andaç Salman
Indian Journal of Skin Allergy (2024) Vol. 3, pp. 87-92
Closed Access | Times Cited: 1
Response to Hasan et al.’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.”
Elaine D. Flynn, Nicholas Leonard, Ryan M. Svoboda
Journal of the American Academy of Dermatology (2024)
Closed Access | Times Cited: 1
Pathomechanism of Adverse Reactions to Biological Treatment of Inflammatory Skin Conditions
Lichen Li, Dean J. Naisbitt, Yonghu Sun, et al.
Clinical & Experimental Allergy (2024) Vol. 54, Iss. 12, pp. 973-983
Open Access | Times Cited: 1
Updated consensus guidelines for management of moderate-to-severe atopic dermatitis in Singapore: Integrating biologics, Janus kinase inhibitors and conventional therapies
Yik Weng Yew, Uma Alagappan, Derrick Chen-Wee Aw, et al.
Annals of the Academy of Medicine Singapore (2024) Vol. 53, Iss. 11, pp. 670-682
Open Access | Times Cited: 1
Dupilumab, Atopic Dermatitis, and Mycosis Fungoides—New Insights on an Evolving Story
Joan Guitart
JAMA Dermatology (2023) Vol. 159, Iss. 11, pp. 1177-1177
Closed Access | Times Cited: 3
A unique case of paraneoplastic lymphomatoid Papuloerythroderma of Ofuji with atypical clinical features
Oluwaseyi Adeuyan, Megan H. Trager, Emily R. Gordon, et al.
JAAD Case Reports (2024) Vol. 50, pp. 102-107
Open Access
Was jetzt?
Wolfgang J. Weninger
hautnah (2024) Vol. 23, Iss. 1, pp. 3-5
Closed Access
Dupilumab’s Duplicity
Warren R. Heymann
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 2, pp. 249-250
Closed Access
Response to Shih et al. “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”
Iraj Hasan, Zachary Zinn
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 5, pp. e139-e140
Closed Access
Response to Hasan et al’s “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study”
Kuan‐Jou Wu, Kai‐Che Wei
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 5, pp. e145-e146
Closed Access
ATOPİK DERMATİT TEDAVİSİNDE BİYOLOJİK İLAÇLAR: LİTERATÜR TARAMASI
Furkan Çalıcıoğlu, Neşecan Çalıcıoğlu, Atıl Avcı, et al.
Journal of Anatolian Medical Research (2024)
Open Access
Response to Flynn et al. “Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.”
Iraj Hasan, Zachary Zinn
Journal of the American Academy of Dermatology (2024) Vol. 92, Iss. 1, pp. e7-e8
Closed Access
Cutaneous T-Cell Lymphoma and Dupilumab Use: A Multifactorial and Complex Story
M. Beylot‐Barry, D. Staumont‐Sallé
Journal of Investigative Dermatology (2024)
Closed Access
Integrative epidemiology and immuno-transcriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy
Javier S. Cabrera‐Perez, Vincent J. Carey, Oreofe O. Odejide, et al.
Journal of Allergy and Clinical Immunology (2024)
Open Access
Skin barrier dysfunction in cutaneous T-cell lymphoma: From pathogenic mechanism of barrier damage to treatment
Pengfei Wen, Xiaoxue Zhuo, Lin Wang
Critical Reviews in Oncology/Hematology (2024) Vol. 205, pp. 104559-104559
Open Access
Hypopigmented mycosis fungoides-like eruption following ixekizumab treatment
Sarah Balboul, Sueheidi Santiago, Gillian Weston, et al.
JAAD Case Reports (2024) Vol. 58, pp. 71-73
Open Access
Quoi de neuf en oncodermatologie ?
Elisa Funck‐Brentano
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S36-8S44
Closed Access
Page 1

Scroll to top